share_log

Pyxis Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(7.87%),Deep Track Biotechnology Master Fund, Ltd.(7.87%), etc.

Pyxis Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(7.87%),Deep Track Biotechnology Master Fund, Ltd.(7.87%), etc.

Pyxis Oncology | SC 13G:超过5%持股股东披露文件-Deep Track Capital, LP(7.87%),Deep Track Biotechnology Master Fund, Ltd.(7.87%)等
美股SEC公告 ·  03/09 05:09
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息